๐Dostawa produktu leczniczego Infliximab
Procurement process summary
This process is to purchase Dostawa produktu leczniczego Infliximab.
This contract was awarded by ๐ต๐ฑ Instytut "Pomnik - Centrum Zdrowia Dziecka" for an amount of PLN 317,076 to 1 supplier. It was published on 2012-11-27 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity๐ต๐ฑ Instytut "Pomnik - Centrum Zdrowia Dziecka" Buying unitnot reported Publication date2012-11-27 Contest statusnot reported DescriptionDostawa produktu leczniczego InfliximabAwards
This award was granted to Centrala Farmaceutyczna CEFARM Spรณลka Akcyjna by Instytut "Pomnik - Centrum Zdrowia Dziecka" for an amount of PLN 317,076. The procurement process was conducted through open for the category of goods. The award was granted on 2012-11-14. This is award number 1.
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| ๐ต๐ฑ Centrala Farmaceutyczna CEFARM Spรณลka Akcyjna | PLN 317,076 | 2012-11-14 | 1 |
Market context and opportunities
The execution of this contract allows the entity Instytut "Pomnik - Centrum Zdrowia Dziecka" to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberPL_ocds-70d2nz-4cda2690-2157-4c0a-b580-3910d4954956-award-1Publication date2012-11-27Contract datenot reportedAward date2012-11-14CategoriesgoodsPurchase modalityopenMethod detailsPNStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
